Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1993 1
1996 2
1998 3
1999 2
2000 1
2002 1
2004 2
2006 1
2007 1
2009 1
2010 1
2011 2
2012 2
2013 2
2014 3
2015 6
2016 3
2017 3
2018 2
2019 6
2020 7
2021 7
2022 2
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Rashed-Un-
Page 1
Pharmacotherapy in Tobacco Cessation: A Narrative Review.
Pajai DD, Paul P, Reche A. Pajai DD, et al. Cureus. 2023 Feb 16;15(2):e35086. doi: 10.7759/cureus.35086. eCollection 2023 Feb. Cureus. 2023. PMID: 36938244 Free PMC article. Review.
This paper will highlight first-line smoking cessation treatments, such as nicotine replacement therapy (NRT), bupropion, and varenicline, and second-line medications, such as clonidine, nortriptyline, anxiolytics, mecamylamine, naltrexone, and NicVAX (Nabi Biopharmaceutic …
This paper will highlight first-line smoking cessation treatments, such as nicotine replacement therapy (NRT), bupropion, and varenicline, a …
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, Agnello M, Agostinis P, Aguilar PV, Aguirre-Ghiso J, Airoldi EM, Ait-Si-Ali S, Akematsu T, Akporiaye ET, Al-Rubeai M, Albaiceta GM, Albanese C, Albani D, Albert ML, Aldudo J, Algül H, Alirezaei M, Alloza I, Almasan A, Almonte-Beceril M, Alnemri ES, Alonso C, Altan-Bonnet N, Altieri DC, Alvarez S, Alvarez-Erviti L, Alves S, Amadoro G, Amano A, Amantini C, Ambrosio S, Amelio I, Amer AO, Amessou M, Amon A, An Z, Anania FA, Andersen SU, Andley UP, Andreadi CK, Andrieu-Abadie N, Anel A, Ann DK, Anoopkumar-Dukie S, Antonioli M, Aoki H, Apostolova N, Aquila S, Aquilano K, Araki K, Arama E, Aranda A, Araya J, Arcaro A, Arias E, Arimoto H, Ariosa AR, Armstrong JL, Arnould T, Arsov I, Asanuma K, Askanas V, Asselin E, Atarashi R, Atherton SS, Atkin JD, Attardi LD, Auberger P, Auburger G, Aurelian L, Autelli R, Avagliano L, Avantaggiati ML, Avrahami L, Awale S, Azad N, Bachetti T, Backer JM, Bae DH, Bae JS, Bae ON, Bae SH, Baehrecke EH, Baek SH, Baghdiguian S, Bagniewska-Zadworna A, Bai H, Bai J, Bai XY, Bailly Y, Balaji KN, … See abstract for full author list ➔ Klionsky DJ, et al. Autophagy. 2016;12(1):1-222. doi: 10.1080/15548627.2015.1100356. Autophagy. 2016. PMID: 26799652 Free PMC article. No abstract available.
Nicotine vaccines.
Fahim RE, Kessler PD, Fuller SA, Kalnik MW. Fahim RE, et al. CNS Neurol Disord Drug Targets. 2011 Dec;10(8):905-15. doi: 10.2174/187152711799219343. CNS Neurol Disord Drug Targets. 2011. PMID: 22229310 Review.
Therapeutic vaccines against tobacco addiction.
Fahim RE, Kessler PD, Kalnik MW. Fahim RE, et al. Expert Rev Vaccines. 2013 Mar;12(3):333-42. doi: 10.1586/erv.13.13. Expert Rev Vaccines. 2013. PMID: 23496672 Review.
Unfortunately, the only vaccine tested in two large, randomized Phase III trials, 3'-amino-methyl-nicotine r-exoprotein A conjugate vaccine (NicVAX(), Nabi Biopharmaceuticals, MD, USA), did not demonstrate efficacy. ...
Unfortunately, the only vaccine tested in two large, randomized Phase III trials, 3'-amino-methyl-nicotine r-exoprotein A conjugate vaccine …
Only change remains permanent.
Nabi G. Nabi G. Scott Med J. 2019 Nov;64(4):125. doi: 10.1177/0036933019883044. Scott Med J. 2019. PMID: 31648629 No abstract available.
Safety profile of WinRho anti-D.
Hong F, Ruiz R, Price H, Griffiths A, Malinoski F, Woloski M. Hong F, et al. Semin Hematol. 1998 Jan;35(1 Suppl 1):9-13. Semin Hematol. 1998. PMID: 9523744 Review.
Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults.
Stoniute A, Madhuvrata P, Still M, Barron-Millar E, Nabi G, Omar MI. Stoniute A, et al. Cochrane Database Syst Rev. 2023 May 9;5(5):CD003781. doi: 10.1002/14651858.CD003781.pub3. Cochrane Database Syst Rev. 2023. PMID: 37160401 Free PMC article. Review.
At the end of the treatment period, anticholinergics may slightly increase condition-specific quality of life (mean difference (MD) 4.41 lower, 95% confidence interval (CI) 5.28 lower to 3.54 lower (scale range -100 to 0); 12 studies, 6804 participants; low-certainty evide …
At the end of the treatment period, anticholinergics may slightly increase condition-specific quality of life (mean difference (MD) 4 …
69 results